QuintilesIMS: Biosimilar Marketing in England Case Solution
QuintilesIMS was a leading health care consulting company best understood for its information and info offerings, as well as its market research study and management consulting services for life science business. By 2015, the business was broadening beyond the biopharmaceutical market, providing analytical services to health care systems, like the National Health Service (NHS) in the United Kingdom (UK). In specific, the business thought about the present usage of biologic medications to deal with RA in England, as well how the intro of biosimilar medications may impact expenses to the NHS and medication gain access to for clients.
This is just an excerpt. This case is about SALES & MARKETING
PUBLICATION DATE: November 04, 2016
Related Case Solutions & Analyses:
General Mills (A)
Basic Industries
First National Bank of Westhaven (B)
Note on Financial Forecasting Problems
Hanson Manufacturing Co.
Ibrahim Dabdoub at the National Bank of Kuwait
Leanwashing: A Hidden Factor in the Obesity Crisis
McDonald’s Corporation
Reorganising Health Care Delivery through a Value-Based Approach
Bad Arguments and Rationalization in Business
